SAT-737 Low-Dose Testosterone Augmentation for Treatment-Resistant Depression in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study

Objective: Nonresponse to selective serotonin reuptake inhibitor and serotonin norepinephrine reuptake inhibitor treatment is common in patients with major depressive disorder (MDD), particularly in women, occurring in about 70% of patients despite adequate dosing. Well-tolerated augmentation strate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Autores principales: Dichtel, Laura E, Carpenter, Linda L, Nyer, Maren, Mischoulon, David, Kimball, Allison, Deckersbach, Thilo, Dougherty, Darin D, Schoenfeld, David, Fisher, Lauren, Cusin, Cristina, Trinh, Nhi-Ha, Pedrelli, Paola, Yeung, Albert, Farabaugh, Amy, Papakostas, George, Chang, Trina, Chen, Justin, Cassano, Paolo, Rao, Elizabeth M, Brady, Roscoe, Singh, Ravinder J, Tyrka, Audrey R, Price, Lawrence, Fava, Maurizio, Miller, Karen Klahr
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207466/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.081
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares